September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Foraviset Welcomes Prof. Tasuku Harada to Advisory Board – Foraviset

Foraviset/LinkedIn

Mar 1, 2026, 16:40

Foraviset Welcomes Prof. Tasuku Harada to Advisory Board – Foraviset

Foraviset shared a post on LinkedIn:

“We are pleased and honored to announce yet another outstanding addition to Foraviset’s expanding Scientific Advisory Board: Prof. Tasuku Harada, President of Tottori University, Japan.

It’s hard to capture Prof. Harada’s career in a single post – but a few highlights speak for themselves:

President, Tottori University (2025– )
Vice President, Tottori University (2023-2025)
Director, Tottori University Hospital (2017-2023)
Professor, Obstetrics and Gynecology, Tottori University Faculty of Medicine (2008-2023)

Prof. Harada is also the former President of the Japan Society of Endometriosis and the Asian Society of Endometriosis and Adenomyosis (ASEA), and has held board roles with the World Endometriosis Society (WES) and the Society of Endometriosis and Uterine Disorders (SEUD).

Prof. Harada graduated from Tottori University in 1983, and trained in IVF-ET at the University of Leeds (UK) in 1985.
He has (co)authored 220+ peer-reviewed publications. He also served as chief investigator in the drug development of eight therapies for endometriosis and dysmenorrhea in Japan, and edited the Springer book ‘Endometriosis Pathogenesis and Treatment’ (2014).

As a member of Foraviset’s Scientific Advisory Board, Prof. Harada will contribute strategic scientific and clinical guidance, support trial readiness, and help strengthen the academic rigor behind our non-hormonal approach to endometriosis and broader uterine health.

We are proud to welcome Prof. Harada at this pivotal stage of our journey.”

Uri Dior, Co-Chief Medical Officer at Foraviset, shared a post, adding:

“Very excited to be joined, on our Scientific Advisory Board, by the esteemed Prof. Tasuku Harada, an inspiring leader in the research and treatment of endometriosis. Welcome.”

Foraviset